Harvard Bioscience, Inc. (HBIO)
8.15
-0.09
(-1.09%)
USD |
NASDAQ |
Oct 13, 15:56
Harvard Bioscience Cash from Investing (Quarterly) : -0.916M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.916M |
| March 31, 2026 | -0.62M |
| December 31, 2025 | -0.599M |
| September 30, 2025 | -0.348M |
| June 30, 2025 | -0.233M |
| March 31, 2025 | -0.683M |
| December 31, 2024 | -0.466M |
| September 30, 2024 | -1.111M |
| June 30, 2024 | 0.458M |
| March 31, 2024 | -0.225M |
| December 31, 2023 | -1.061M |
| September 30, 2023 | -0.401M |
| June 30, 2023 | -0.625M |
| March 31, 2023 | 0.288M |
| December 31, 2022 | -0.235M |
| September 30, 2022 | -0.442M |
| June 30, 2022 | -0.442M |
| March 31, 2022 | -0.471M |
| December 31, 2021 | -0.358M |
| September 30, 2021 | -0.48M |
| June 30, 2021 | -0.206M |
| March 31, 2021 | -0.301M |
| December 31, 2020 | -0.314M |
| September 30, 2020 | -0.564M |
| June 30, 2020 | -0.283M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.241M |
| December 31, 2019 | -0.456M |
| September 30, 2019 | -0.361M |
| June 30, 2019 | 0.74M |
| March 31, 2019 | -0.152M |
| December 31, 2018 | -0.627M |
| September 30, 2018 | -0.257M |
| June 30, 2018 | -0.723M |
| March 31, 2018 | -52.19M |
| December 31, 2017 | -0.201M |
| September 30, 2017 | -0.24M |
| June 30, 2017 | -0.248M |
| March 31, 2017 | -0.228M |
| December 31, 2016 | 0.892M |
| September 30, 2016 | -0.542M |
| June 30, 2016 | -0.207M |
| March 31, 2016 | -0.205M |
| December 31, 2015 | -0.68M |
| September 30, 2015 | -0.667M |
| June 30, 2015 | -0.581M |
| March 31, 2015 | -5.589M |
| December 31, 2014 | -12.37M |
| September 30, 2014 | -0.482M |
| June 30, 2014 | -0.497M |
| March 31, 2014 | -0.169M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Agilent Technologies, Inc. | -1.032B |
| Bio-Rad Laboratories, Inc. | -66.70M |
| Bruker Corp. | -25.30M |
| Danaher Corp. | -10.15B |
| Illumina, Inc. | -122.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 0.323M |
| Cash from Financing (Quarterly) | -0.036M |
| Free Cash Flow | -1.53M |
| Free Cash Flow Per Share (Quarterly) | -0.131 |
| Free Cash Flow to Equity (Quarterly) | -0.677M |
| Free Cash Flow to Firm (Quarterly) | 1.209M |
| Free Cash Flow Yield | -4.19% |